| Mrs Christine Annette Forte, LICSW | |
|
44 School St, Westerly, RI 02891-2220 | |
| (718) 974-0244 | |
| Not Available |
| Full Name | Mrs Christine Annette Forte |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 44 School St, Westerly, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467768564 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | ISW02025 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Christine Annette Forte, LICSW 44 School St, Westerly, RI 02891-2220 Ph: () - | Mrs Christine Annette Forte, LICSW 44 School St, Westerly, RI 02891-2220 Ph: (718) 974-0244 |
News Archive
In an article published in the March issue of the Journal of Cardiovascular Pharmacology and Therapeutics, researchers from Florida Atlantic University (FAU) assess the totality of evidence, including strengths and limitations of different types of evidence contributing to the debate about cardiovascular disease (CVD) risks of cyclooxygenase-2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs).
In the wake of multiple state bans on caffeinated alcoholic beverages (CABs) and an FDA warning to four companies to remove their products from the marketplace, an article published online today in the American Journal of Preventive Medicine delineates the scope of the public health problem and suggests areas of research that might help address it.
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that patient dosing has begun in the AdV HALT Trial (A Randomized, Placebo-Controlled, Multi-site Phase 2 Study Evaluating the Safety and Efficacy of Preemptive Treatment with CMX001 for the Prevention of Adenovirus Disease Following Hematopoietic Stem Cell Transplantation [HSCT]).
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
› Verified 2 days ago
Erin Pringer, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21 Canal St Unit 201, Westerly, RI 02891 Phone: 401-932-0160 | |
Ms. Jessica Johanna Wolke, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 21 Canal St, Suite 201, Westerly, RI 02891 Phone: 401-596-8830 Fax: 401-596-8802 | |
Ms. Jennifer Spivey-rachlin, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 85 Beach St, Bldg. B Upper Level, Westerly, RI 02891 Phone: 401-506-6866 Fax: 401-596-0493 | |
Ms. Katherine Anne Chesson, MSW, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 16 High St Ste 6, Westerly, RI 02891 Phone: 401-219-1133 Fax: 401-596-1826 | |
Leslie J Gordon, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 81 Rossini Rd, Westerly, RI 02891 Phone: 401-322-2678 | |
Marie-claire Cornillon, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 43 Broad St, Westerly, RI 02891 Phone: 401-596-2302 | |
Kimberly Kralicky, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 25 Wells St, The Westerly Hospital, Westerly, RI 02891 Phone: 401-348-3972 Fax: 401-348-3436 |